Patents by Inventor Mark Vaughan

Mark Vaughan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240359139
    Abstract: An apparatus and method for transferring a fluid sample from a fluid sample collection apparatus to a liquid sample analyzer. The apparatus includes a barrel having a first end, a second end, a sidewall extending between the first end and the second end, and an inner surface defining an internal chamber. The first end has an inlet opening and the second end having an outlet opening. The first end of the barrel has a barrel connection portion engageable with a portion of the fluid sample collection apparatus and the second end of the barrel has a tubular portion configured to engage with the liquid sample analyzer so a combination of the fluid sample collection apparatus and the barrel is attachable to the liquid sample analyzer with no additional support.
    Type: Application
    Filed: August 5, 2022
    Publication date: October 31, 2024
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Janine Cox, Michael Chen, Mark Vaughan, Justin DeSilva, Joshua Joseph, Justin Davis
  • Publication number: 20240309715
    Abstract: A technique facilitates a drilling operation, e.g. a land-based drilling operation, by enabling a substantial reduction in the number of equipment components. According to an embodiment, a mud pump assembly is provided with at least one mud pump located on a rig positioned at a wellsite. Electric power is provided to the rig to enable operation of the rig, including operation of the mud pumps when pumping mud downhole to facilitate drilling of a borehole. The rig's electric power also is used to operate a cement mixer for mixing a cementing fluid. This cementing fluid may be pumped downhole during a cementing operation by the same mud pumps employed during the mud pumping operation.
    Type: Application
    Filed: July 12, 2023
    Publication date: September 19, 2024
    Inventors: Bartley Patton, William Troy Huey, Mark Vaughan
  • Publication number: 20240309727
    Abstract: A technique facilitates a drilling operation, e.g. a land-based drilling operation, by enabling a substantial reduction in the number of equipment components. According to an embodiment, a mud pump assembly is provided with at least one mud pump located on a rig positioned at a wellsite. The mud pumps may be run to perform a mud pumping operation by pumping mud downhole during drilling of a borehole, e.g. a wellbore. During stoppage of the mud pumping operation, the same mud pumps are utilized to perform a cementing operation in which cementing fluid is pumped downhole for cementing of casing. The use of the same mud pumps enables the operator to eliminate not only the separate cement pumps otherwise used for the cementing operation but also the motive units that would be associated with those separate cement pumps.
    Type: Application
    Filed: July 12, 2023
    Publication date: September 19, 2024
    Inventors: Bartley Patton, William Troy Huey, Mark Vaughan
  • Publication number: 20240286139
    Abstract: An apparatus and method for transferring a fluid sample from a fluid sample collection apparatus to a liquid sample analyzer. The apparatus includes a barrel having a first end, a second end, a sidewall extending between the first end and the second end, an inner surface defining an internal chamber, and an external surface defining at least a portion of a chromatographic assay chamber in fluid communication with the internal chamber. The first end has an inlet opening with a clot catcher extending across the inlet opening upstream of the passage and the second end has an outlet opening. A chromatographic assay assembly is housed in the chromatographic assay chamber for detecting presence of free hemoglobin in the fluid sample.
    Type: Application
    Filed: August 5, 2022
    Publication date: August 29, 2024
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Janine Cox, Michael Chen, Justin Davis, Justin DeSilva, Mark Vaughan, Joshua Joseph
  • Publication number: 20240269304
    Abstract: Antibody-drug conjugates that bind to human oncology targets are disclosed. The antibody-drug conjugates comprise a Bcl-xL inhibitor drug moiety. The disclosure farther relates to methods and compositions for use in the treatment of cancers by administering the antibody-drug conjugates provided herein. Linker-drug conjugates comprising Bcl-xL inhibitor drug moiety and methods of making same are also disclosed.
    Type: Application
    Filed: November 23, 2021
    Publication date: August 15, 2024
    Inventors: Matthew T. Burger, Zhuoliang Chen, Joseph Anthony D'Alessio, Eric McNeill, Katsumasa Nakajima, Richard Vaughan Newcombe, Mark G. Palermo, Bing Yu, Qiang Zhang, Frédéric Colland, James Edward Paul Davidson, Lea Delacour, Patrice Desos, Olivier Geneste, Vesela Kostova, Andras Kotschy, Ana Leticia Maragno, James Brooke Murray, Tibor Novak, Jérôme Benoit Starck
  • Patent number: 11952124
    Abstract: An aircraft tray table may include a body with a defined interior cavity, a personal electronic device support, and a magnification lens. The personal electronic device support may be configured to hold a personal electronic device when the personal electronic device support is in a support deployed position. The magnification lens may be configured to fit within the interior cavity when the magnification lens is in a lens stowed position. The magnification lens may include a lens configured to magnify content displayed on the personal electronic device held by the personal electronic device support when the magnification lens is in a lens deployed position. The personal electronic device support may be parallel to the magnification lens when the personal electronic device is in the support deployed position and the magnification lens is in the lens deployed position.
    Type: Grant
    Filed: April 22, 2021
    Date of Patent: April 9, 2024
    Assignee: B/E Aerospace, Inc.
    Inventors: Ian L. Frost, Daniel I. Udriste, Charles Zurian, Mark Vaughan
  • Publication number: 20240001252
    Abstract: An electrically conducting toy building block comprising: a body having a top surface and a bottom surface, and a plurality of evenly spaced connector studs projecting from the top surface, and an internal cavity that is open to the bottom surface and is sized to accommodate the top surface of another block and frictionally engage the connector studs of said other block to enable multiple blocks to be connected. The connectors studs comprise electrically non-conductive studs and electrically conductive studs. The electrically conductive connector studs comprise a top portion having external dimensions matching the non-electrically conducting stud, and an elongate telescoping member that extends downward from the top portion into the cavity. The telescoping member comprises an outer barrel and an inner plunger slidably received in the barrel, the plunger including a stop to prevent complete withdrawal of the plunger from the barrel, and the plunger being biased towards being extended from the barrel.
    Type: Application
    Filed: May 4, 2023
    Publication date: January 4, 2024
    Inventor: Mark VAUGHAN
  • Publication number: 20210339870
    Abstract: An aircraft tray table may include a body with a defined interior cavity, a personal electronic device support, and a magnification lens. The personal electronic device support may be configured to hold a personal electronic device when the personal electronic device support is in a support deployed position. The magnification lens may be configured to fit within the interior cavity when the magnification lens is in a lens stowed position. The magnification lens may include a lens configured to magnify content displayed on the personal electronic device held by the personal electronic device support when the magnification lens is in a lens deployed position. The personal electronic device support may be parallel to the magnification lens when the personal electronic device is in the support deployed position and the magnification lens is in the lens deployed position.
    Type: Application
    Filed: April 22, 2021
    Publication date: November 4, 2021
    Inventors: Ian L. Frost, Daniel I. Udriste, Charles Zurian, Mark Vaughan
  • Publication number: 20200024628
    Abstract: The present invention relates to a novel endoglycoceramidase whose hydrolytic activity has been substantially reduced or eliminated, such that the enzyme is useful for synthesis of glycolipids from a monosaccharide or oligosaccharide and a ceramide. More specifically, the endoglycoceramidase is a mutant version of a naturally occurring endoglycoceramidase, preferably comprising a mutation within the active site or the nucleophilic site of the enzyme and more preferably comprising a substitution mutation of the Glu residue within the active site or the nucleophilic site. Also disclosed are a method for generating the mutant endoglycoceramidase and a method for enzymatically synthesizing glycolipids using this mutant enzyme.
    Type: Application
    Filed: May 17, 2019
    Publication date: January 23, 2020
    Inventors: Karl F. Johnson, Shawn DeFrees, Stephen Withers, Mark Vaughan
  • Patent number: 10430037
    Abstract: A method of controlling webpage behaviour on a web enabled device 3 in order to assist in, for example, collection of monitoring information, preserving session context, and improving security. The method includes monitoring a user interaction with a webpage (step 203), using a client side module 31 at the web enabled device 3, and determining whether predetermined conditions are satisfied (step 204). Where the predetermined conditions are satisfied the further steps below are carried out: capturing details concerning an intended result of said user interaction (step 205), using the client side module; at least temporarily preventing occurrence of the intended result of said user interaction using the client side module (step 206); carrying out additional processing (step 207) using the client side module; determining a controlled result (step 208), using the client side module, in dependence on said intended result and the additional processing; and causing the controlled result to occur (step 209).
    Type: Grant
    Filed: March 6, 2012
    Date of Patent: October 1, 2019
    Assignee: D4T4 SOLUTIONS PLC
    Inventors: Dara James Edward O'Donnell, Lincoln Mark Vaughan Goldspink
  • Patent number: 10294504
    Abstract: The present invention relates to a novel endoglycoceramidase whose hydrolytic activity has been substantially reduced or eliminated, such that the enzyme is useful for synthesis of glycolipids from a monosaccharide or oligosaccharide and a ceramide. More specifically, the endoglycoceramidase is a mutant version of a naturally occurring endoglycoceramidase, preferably comprising a mutation within the active site or the nucleophilic site of the enzyme and more preferably comprising a substitution mutation of the Glu residue within the active site or the nucleophilic site. Also disclosed are a method for generating the mutant endoglycoceramidase and a method for enzymatically synthesizing glycolipids using this mutant enzyme.
    Type: Grant
    Filed: June 29, 2015
    Date of Patent: May 21, 2019
    Assignees: La Jolla Pharmaceutical Company, The University of British Columbia
    Inventors: Karl F. Johnson, Shawn Defrees, Stephen Withers, Mark Vaughan
  • Publication number: 20190133887
    Abstract: The Rx Secure medication dispenser is the only product of its kind that features an integrated alarm system which will automatically emit an audible sound along with flashing lights in attempt to notify the user of medication that needs to be taken; any attempts to tamper with or open the device will result in an alert that will be provided to their doctor or caregiver immediately. The Rx Secure is uniquely designed to be manufactured with Plexiglas and metal materials for maximum durability and is intended to be available with a battery back-up as an added safeguard to provide optimal security and to prevent abuse.
    Type: Application
    Filed: June 14, 2017
    Publication date: May 9, 2019
    Inventor: MARK VAUGHAN
  • Publication number: 20160032342
    Abstract: The present invention relates to a novel endoglycoceramidase whose hydrolytic activity has been substantially reduced or eliminated, such that the enzyme is useful for synthesis of glycolipids from a monosaccharide or oligosaccharide and a ceramide. More specifically, the endoglycoceramidase is a mutant version of a naturally occurring endoglycoceramidase, preferably comprising a mutation within the active site or the nucleophilic site of the enzyme and more preferably comprising a substitution mutation of the Glu residue within the active site or the nucleophilic site. Also disclosed are a method for generating the mutant endoglycoceramidase and a method for enzymatically synthesizing glycolipids using this mutant enzyme.
    Type: Application
    Filed: June 29, 2015
    Publication date: February 4, 2016
    Applicants: Seneb Biosciences, Inc., The University of British Columbia
    Inventors: Karl F. JOHNSON, Shawn DEFREES, Stephen WITHERS, Mark VAUGHAN
  • Patent number: 9068208
    Abstract: The present invention relates to a novel endoglycoceramidase whose hydrolytic activity has been substantially reduced or eliminated, such that the enzyme is useful for synthesis of glycolipids from a monosaccharide or oligosaccharide and a ceramide. More specifically, the endoglycoceramidase is a mutant version of a naturally occurring endoglycoceramidase, preferably comprising a mutation within the active site or the nucleophilic site of the enzyme and more preferably comprising a substitution mutation of the Glu residue within the active site or the nucleophilic site. Also disclosed are a method for generating the mutant endoglycoceramidase and a method for enzymatically synthesizing glycolipids using this mutant enzyme.
    Type: Grant
    Filed: July 24, 2013
    Date of Patent: June 30, 2015
    Assignee: Seneb Biosciences, Inc.
    Inventors: Karl F. Johnson, Shawn Defrees, Stephen Withers, Mark Vaughan
  • Patent number: 8898309
    Abstract: A method and apparatus for setting cookies on client devices 6, in particular for allowing maintenance of cross domain session continuity. A server 5 is provided for extracting a session ID from a first party cookie in the domain of the server 5 which is included in a HTTP request generated by a page 8 from a different domain active in a browser 7. Code is returned by the server 5 to that page 8 to cause it to generate a first party cookie in its domain which includes the extracted session ID.
    Type: Grant
    Filed: January 29, 2007
    Date of Patent: November 25, 2014
    Assignee: Speed-Trap.com Ltd.
    Inventors: Lincoln Mark Vaughan Goldspink, Malcolm John Duckett
  • Publication number: 20140147891
    Abstract: The present invention relates to a novel endoglycoceramidase whose hydrolytic activity has been substantially reduced or eliminated, such that the enzyme is useful for synthesis of glycolipids from a monosaccharide or oligosaccharide and a ceramide. More specifically, the endoglycoceramidase is a mutant version of a naturally occurring endoglycoceramidase, preferably comprising a mutation within the active site or the nucleophilic site of the enzyme and more preferably comprising a substitution mutation of the Glu residue within the active site or the nucleophilic site. Also disclosed are a method for generating the mutant endoglycoceramidase and a method for enzymatically synthesizing glycolipids using this mutant enzyme.
    Type: Application
    Filed: July 24, 2013
    Publication date: May 29, 2014
    Applicants: The University of British Columbia University- Industry Liaison Office, Seneb BioSciences, Inc.
    Inventors: Karl F. Johnson, Shawn Defrees, Stephen Withers, Mark Vaughan
  • Publication number: 20140047866
    Abstract: A system and method for exhibiting granular material in an ornamental assembly. The sand represents a tangible embodiment of memories and emotional ties to a specific region. A transparent, flexible inner chamber holds the sand, and joins at two ends via a mating portion and a fastener. A similarly transparent, flexible outer portion encloses and contours to the shape of the inner chamber.
    Type: Application
    Filed: August 19, 2012
    Publication date: February 20, 2014
    Inventor: MARK VAUGHAN
  • Publication number: 20140026081
    Abstract: A method of controlling webpage behaviour on a web enabled device 3 in order to assist in, for example, collection of monitoring information, preserving session context, and improving security. The method includes monitoring a user interaction with a webpage (step 203), using a client side module 31 at the web enabled device 3, and determining whether predetermined conditions are satisfied (step 204). Where the predetermined conditions are satisfied the further steps below are carried out: capturing details concerning an intended result of said user interaction (step 205), using the client side module; at least temporarily preventing occurrence of the intended result of said user interaction using the client side module (step 206); carrying out additional processing (step 207) using the client side module; determining a controlled result (step 208), using the client side module, in dependence on said intended result and the additional processing; and causing the controlled result to occur (step 209).
    Type: Application
    Filed: March 6, 2012
    Publication date: January 23, 2014
    Applicant: CELBRUS TECHNOLOGIES LIMITED
    Inventors: Dara James Edward O'donnell, Lincoln Mark Vaughan Goldspink
  • Publication number: 20090170155
    Abstract: The present invention relates to a novel endoglycoceramidase whose hydrolytic activity has been substantially reduced or eliminated, such that the enzyme is useful for synthesis of glycolipids from a monosaccharide or oligosaccharide and a ceramide. More specifically, the endoglycoceramidase is a mutant version of a naturally occurring endoglycoceramidase, preferably comprising a mutation within the active site or the nucleophilic site of the enzyme and more preferably comprising a substitution mutation of the Glu residue within the active site or the nucleophilic site. Also disclosed are a method for generating the mutant endoglycoceramidase and a method for enzymatically synthesizing glycolipids using this mutant enzyme.
    Type: Application
    Filed: June 1, 2005
    Publication date: July 2, 2009
    Applicant: THE UNIVERSITY OF BRITISH COLUMBIA UNIVERSITY-INDU
    Inventors: Karl F. Johnson, Shawn Defrees, Stephen Withers, Mark Vaughan
  • Patent number: D1043975
    Type: Grant
    Filed: January 13, 2023
    Date of Patent: September 24, 2024
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Janine Cox, Michael Chen, Justin DeSilva, Justin Davis, Mark Vaughan